Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for June, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- Roundtable Top Picks of the Week
- FED Front & Center Again
- RTI: Sector Strength Charts - Where's the Opportunity Now?
- Surging Financial ETFs Beating the Market
- Utility Industry Stock Outlook - June 2013
- 3 Japanese Stocks to Buy Now
- Your Next Stock Should Be Making New Highs
- Anatomy of Success: Stoneridge (SRI)
- RTI: What Will the Fed Do Wednesday?
- AWS 6/18: Can the Fed Afford to Keep the Suspense?
- PFP 6/18: Wednesday Fed Watch
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 06/18/2013
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
•Beat Buy (NYSE:BBY) reported Q4 EPS today of $1.98, beating the Zacks Consensus Estimate of $1.84 per share. Revenue for the quarter was down 1.8% year-over-year to $16.3 billion higher than the Zacks Consensus Estimate of $16.298 billion
•Walgreen Co. (NYSE:WAG) reported its plan to purchase online pharmacy drugstore.com inc (NASDAQ:DSCM) for $3.80 a share, or about $409 million
•Medical-device manufacturer TranS1 Inc (NASDAQ:TSON) said U.S. regulators had cleared its spinal implant system
•On late Wednesday, MediciNova Inc's (NASDAQ:MNOV) announced an $8.25 million public offering of stock and warrants
•Madison Williams analysts initiated coverage on Kinder Morgan (NYSE: KMI) setting a target price of $34.00 with “accumulate” rating
•Howard Weil analysts initiated coverage on McDermott International (NYSE: MDR) with an “Outperform” rating with a target price of $30.00
•Oppenheimer initiated coverage on Sky-mobi (NASDAQ: MOBI) with an “Outperform” rating and with a target price of $14.00
•Citigroup (NYSE:C) initiated coverage on shares of SuccessFactors, Inc. (NASDAQ: SFSF) with a “Buy” rating with a target price of $45.00 per share
•Citigroup (NYSE:C) initiated coverage on shares of Taleo Corp (NASDAQ: TLEO) with a “Buy” rating and a $44.00 price target on the stock
Get the full Analyst Report on BBY - FREE
Get the full Analyst Report on WAG - FREE
Get the full on MNOV - FREE
Get the full Analyst Report on KMI - FREE
Get the full Analyst Report on MDR - FREE
Get the full Snapshot Report on MOBI - FREE
Get the full Analyst Report on C - FREE